Increasing investments in the field of R&D of drugs is contributing to the growth of the market. Along with this, the rising geriatric population also drives the market upwards. Cigarette smoking is a strong risk factor that leads to substantial growth in Rheumatoid Arthritis market. The presence of high-cost drugs and favorable reimbursement policies are the most prominent driving factors for the growth of the market. The anti –TNF factors are used as first-line treatment for RA, but owing to the launch of new biologics in the global market is likely to hamper the demand for TNF inhibitors.